HCA Healthcare (US.HCA)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.HCA · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 46.0% | ↓ |
| ROE | - | → |
| Cash Conversion | 131.0% | ↓ |
| D/E Ratio | - | → |
| Gross Margin | 43.3% | ↑ |
US.HCA (HCA Healthcare) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY ---------------------------- FCF Conversion 46.0% ↓ ROE - → Cash Conversion 131.0% ↓ D/E Ratio - → Gross Margin 43.3% ↑
Key Metrics
US.HCA (HCA Healthcare) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY----------------------------FCF Conversion 46.0% ↓ROE - →Cash Conversion 131.0% ↓D/E Ratio - →Gross Margin 43.3% ↑Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies